サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1611033

神経血栓除去装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測、2025年～2030年

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecast, 2025 - 2030

出版日
ページ情報
英文 154 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
神経血栓除去装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年11月14日
発行: Grand View Research
ページ情報: 英文 154 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経血栓摘出装置市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の神経血栓除去装置市場規模は2025～2030年にかけてCAGR 6.94％を記録し、2030年には11億米ドルに達する見込みです。

市場の成長は、脳卒中の有病率の増加、不健康なライフスタイルの採用の増加、低侵襲手術の需要の増加、市場参入企業による様々な戦略的イニシアチブの採用など、様々な要因によって牽引されています。従来の開頭手術と比較して、これらのデバイスは創傷閉鎖を簡素化し、創傷治癒を早める利点を記載しています。例えば、頭蓋内腔への容易なアクセス、最小限の侵襲、神経血栓摘出デバイスに関連する先進的設計と機能による困難な処置の簡素化などがあります。

さらに、あらゆる年齢層でより審美的で自然な外観への関心が高まっていることや、低侵襲手術中の出血量が少ないことも市場成長の主要促進要因の一つです。このような処置は、侵襲的処置よりもさらに外傷を減らし、迅速な回復を促進するのに役立つと期待されています。このように、神経血栓除去装置は出血量が少なく、回復も早いため、低侵襲手術の需要が高まると予想されています。さらに、技術的に先進的製品の採用と迅速な製品承認プロセスは、予測期間中の市場成長を促進すると予想される要因です。AISとその関連症状の治療のための神経血栓除去装置の開発には、他にもさまざまな技術が用いられています。例えば、2023年6月、Penumbraはlightning Bolt7動脈血栓除去システムを発表しました。この装置は、血栓と血流の違いを識別するのに役立ちます。

神経血栓摘出装置市場レポートハイライト

  • 製品別では、急性虚血性脳卒中の有病率の上昇と主要市場参入企業による製品発売の増加により、血栓回収装置が57.8%のシェアを占め、2024年の市場を独占しました。
  • 最終用途別では、医療施設の改善と病院での先進的機器の利用可能性により、病院セグメントが2024年に70.4％のシェアで市場を独占しました。
  • 欧州は、急性虚血性脳卒中患者の増加により、2024年に32.9%の最大売上シェアで市場をリードしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 神経血栓除去装置市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 神経血栓除去装置市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 神経血栓除去装置市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • 神経血栓除去装置市場：製品変動分析、2024年と2030年
  • クロットレトリーバー
  • 吸引装置
  • 血管スネア

第5章 神経血栓除去装置市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 神経血栓除去装置市場：最終用途変動分析、2024年と2030年
  • 病院
  • 救急クリニック
  • 外来手術センター

第6章 神経血栓除去装置市場：地域別、推定・動向分析

  • 神経血栓除去装置の市場シェア、地域別、2024年と2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Medtronic
    • Stryker
    • Acandis GmbH
    • Phenox GmbH
    • Penumbra
    • Vesalio, LLC.
    • Terumo Corporation
    • MIVI Neuroscience, Inc.
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • Rapid Medical
    • Infinity Neuro
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S neurothrombectomy devices, by end use, 2018 - 2030 (USD Million)
  • Table 8 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Mexico neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 19 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 France neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 China neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Japan neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 38 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 India neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 South Korea neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Thailand neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 UAE neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 Kuwait neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neurothrombectomy device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Neurothrombectomy device market: Product movement analysis
  • Fig. 19 Segment dashboard
  • Fig. 20 Neurothrombectomy device market product outlook: Key takeaways
  • Fig. 21 Clot retrievers market, 2018 - 2030 (USD Million)
  • Fig. 22 Aspiration/ suction devices market, 2018 - 2030 (USD Million)
  • Fig. 23 Vascular snares market, 2018 - 2030 (USD Million)
  • Fig. 24 Neurothrombectomy device market: End Use movement analysis
  • Fig. 25 Segment dashboard
  • Fig. 26 Neurothrombectomy device market end use outlook: Key takeaways
  • Fig. 27 Hospital market, 2018 - 2030 (USD Million)
  • Fig. 28 Emergency clinics market, 2018 -- 2030 (USD Million)
  • Fig. 29 Ambulatory Surgical Centers market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Regional market dashboard
  • Fig. 32 Regional market place: Key takeaways
  • Fig. 33 North America neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 34 US neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 37 UK neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 39 France neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 44 China neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 45 India neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 51 MEA neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 55 Company market share analysis, 2024
目次
Product Code: GVR-2-68038-941-8

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

  • Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.
  • Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.
  • Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neurothrombectomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of suppliers
      • 3.4.1.2. Bargaining power of buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurothrombectomy Devices Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Clot Retrievers
    • 4.3.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Aspiration/Suction Devices
    • 4.4.1. Aspiration/Suction Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Vascular Snares
    • 4.5.1. Vascular Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurothrombectomy Devices Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Emergency Clinics
    • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Neurothrombectomy Devices Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Mexico Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Japan Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. China Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Argentina Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. South Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Saudi Arabia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Stryker
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Acandis GmbH
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Phenox GmbH
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Penumbra
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Vesalio, LLC.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Terumo Corporation
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. MIVI Neuroscience, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Rapid Medical
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Infinity Neuro
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives